title: Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene.
authors.forename: Ambra
authors.initials: A
authors.lastname: Di Veroli
authors.forename: Safaa M
authors.initials: SM
authors.lastname: Ramadan
authors.forename: Mariadomenica
authors.initials: M
authors.lastname: Divona
authors.forename: Laura
authors.initials: L
authors.lastname: Cudillo
authors.forename: Laura
authors.initials: L
authors.lastname: Giannì
authors.forename: Scott
authors.initials: S
authors.lastname: Wieland
authors.forename: Federica
authors.initials: F
authors.lastname: Giannotti
authors.forename: Milena
authors.initials: M
authors.lastname: Mirabile
authors.forename: William
authors.initials: W
authors.lastname: Arcese
authors.forename: Francesco
authors.initials: F
authors.lastname: Lo-Coco
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D012008:Recurrence; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001565:Benzoates; D013764:Tetrahydronaphthalenes; C061133:tamibarotene